Stay updated on Acalabrutinib Pembrolizumab Combo in Head & Neck Cancer Clinical Trial

Sign up to get notified when there's something new on the Acalabrutinib Pembrolizumab Combo in Head & Neck Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Acalabrutinib Pembrolizumab Combo in Head & Neck Cancer Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The page revision tag was updated to v3.5.4 (replacing v3.5.3), indicating a new version of the page. This appears to be routine maintenance and does not alter study content or user-facing information.
    Difference
    0.1%
    Check dated 2026-05-14T23:14:11.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.5.2 to v3.5.3, reflecting a minor update to the page's version history.
    Difference
    0.1%
    Check dated 2026-04-30T16:10:47.000Z thumbnail image
  4. Check
    25 days ago
    No Change Detected
  5. Check
    32 days ago
    Change Detected
    Summary
    Footer revision tag changed from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-16T09:33:34.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    The page footer lists Revision: v3.5.0, replacing Revision: v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-25T20:12:16.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    Footer revision updated from v3.4.2 to v3.4.3. No study content or user-facing functionality were changed.
    Difference
    0.1%
    Check dated 2026-03-11T11:37:35.000Z thumbnail image
  8. Check
    97 days ago
    Change Detected
    Summary
    Added site Revision: v3.4.2. Removed the government funding/operating status notice from the page.
    Difference
    0.5%
    Check dated 2026-02-11T02:18:09.000Z thumbnail image

Stay in the know with updates to Acalabrutinib Pembrolizumab Combo in Head & Neck Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Acalabrutinib Pembrolizumab Combo in Head & Neck Cancer Clinical Trial page.